Cargando…
Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Non-small cell lung cancer treatment has undergone a revolution in the past decade owing to the discovery of mutations that drive carcinogenesis and the development of molecular testing and treatments that act on them. Here, we detail the way in which lung cancer is currently diagnos...
Autores principales: | de Jong, Dorine, Das, Jeeban P., Ma, Hong, Pailey Valiplackal, Jacienta, Prendergast, Conor, Roa, Tina, Braumuller, Brian, Deng, Aileen, Dercle, Laurent, Yeh, Randy, Salvatore, Mary M., Capaccione, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216085/ https://www.ncbi.nlm.nih.gov/pubmed/37345192 http://dx.doi.org/10.3390/cancers15102855 |
Ejemplares similares
-
Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer
por: Ma, Hong Yun, et al.
Publicado: (2023) -
Advances in PET/CT Imaging for Breast Cancer
por: de Jong, Dorine, et al.
Publicado: (2023) -
More than Just Skin-Deep: A Review of Imaging’s Role in Guiding CAR T-Cell Therapy for Advanced Melanoma
por: Prendergast, Conor M., et al.
Publicado: (2023) -
Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022) -
Integrating [(18)F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors
por: Prendergast, Conor M., et al.
Publicado: (2023)